Early Data for bluebird bio Gene-Therapy Candidate Show Some Promise – Genetic Engineering & Biotechnology News
STAT |
Early Data for bluebird bio Gene–Therapy Candidate Show Some Promise
Genetic Engineering & Biotechnology News bluebird bio today disclosed its first data, including some promising results, from a pair of clinical studies assessing its LentiGlobin™ gene therapy candidate—including a Phase III study that followed a change in its manufacturing process. In the … Bluebird Bio's gene therapy for blood disorders yields some impressive results ― but also raises questions Bluebird Reports Early Results From Upgraded Gene Therapy Bluebird bio steps up with a promising snapshot of its gene therapy upgrade |
